December 28, 2023 | NEJM
Image Challenge from the New England Journal of Medicine — December 28, 2023
Image Challenge from the New England Journal of Medicine — December 28, 2023
If sex-based differences in risk result from biased care rather than biology, enshrining the associations in clinical algorithms may be inequitable and unlawful. How can…
Allogeneic hematopoietic stem-cell transplantation is the only curative treatment for myelofibrosis. Driver mutations are the pathophysiological hallmark of the disease, but the role of mutation…
Image Challenge from the New England Journal of Medicine — January 9, 2025
This report describes a novel tickborne orthonairovirus species identified in patients presenting with an acute febrile illness in China.
A 35-year-old woman was admitted at 8 weeks postpartum because of shortness of breath and edema in the legs. Proteinuria had developed at the end…
Talquetamab (anti–G protein–coupled receptor family C group 5 member D) and teclistamab (anti–B-cell maturation antigen) are bispecific antibodies that activate T cells by targeting CD3…
Policy solutions are needed to cover adequate health care for the approximately 1.1 million older, low-income adults in the United States who are undocumented immigrants.
NEK7 phosphorylation amplifies NLRP3 activation.
ACAAI Member, full access to the journal is a member benefit. Use your society credentials to access all journal content and features. In celebration of…
Heart failure with preserved ejection fraction is noted for symptoms of heart failure, LVEF of at least 50%, and cardiac or structural abnormalities. Treatment includes…